Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986165 Phase 3 in Moderate to Severe Plaque Psoriasis
CTR20190979Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deucravacitinib in psoriasis, nail psoriasis, sponsored by Bristol Myers Squibb. Started Jun 2019; status: completed.
02
Drugs
deucravacitinib
03
Conditions
psoriasisnail psoriasis
Beyond the preview
Go deeper on CTR20190979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190979.